CHRISTINE PRATT: Open Payments
NPI 1033201074 · PEORIA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,142 in 59 payments from 20 companies in 2025. Trend: 2023 $1,639 · 2024 $1,990 · 2025 $1,142
Food & beverage: $1,110Consulting: $32
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 12 | $222 |
| GlaxoSmithKline, LLC. | 13 | $182 |
| Novartis Pharmaceuticals Corporation | 4 | $94 |
| CSL Behring | 3 | $75 |
| Octapharma USA, Inc. | 2 | $63 |
| Blueprint Medicines Corporation | 2 | $56 |
| Genentech USA, Inc. | 2 | $54 |
| Grifols USA, LLC | 2 | $53 |
| Lilly USA, LLC | 2 | $44 |
| BioCryst US Sales Co., LLC | 2 | $40 |
Products named: DUPIXENT, NUCALA, AYVAKIT, Xolair, Xembify, Haegarda, ORLADEYO, ALYGLO.
Industry payments across AZ — which companies pay providers there.
